Incretin Defect Framework
Understanding incretin-related glucose dysregulation
The Incretin Defect Framework involves identifying and addressing incretin-related glucose dysregulation, which can contribute to conditions such as type 2 diabetes. This framework recognizes the importance of incretins, such as GLP-1, in glucose regulation and the potential for defects or imbalances in this system.
- Incretins play a crucial role in glucose regulation.
- Defects or imbalances in the incretin system can contribute to glucose dysregulation.
- Targeted interventions can help address incretin-related glucose dysregulation.
- Assess Incretin FunctionEvaluate incretin function and identify potential defects or imbalances.Pro tipUtilize advanced testing methods, such as GLP-1 assays, to assess incretin function.WarningInaccurate assessment of incretin function may lead to ineffective treatment or lifestyle changes.
- Implement Incretin-Based TherapiesInitiate therapies that target the incretin system, such as GLP-1 receptor agonists, to address glucose dysregulation.Pro tipConsult with a healthcare professional to determine the best course of treatment.WarningInappropriate use of incretin-based therapies may lead to adverse effects or poor glucose control.
Case Study: GLP-1 Receptor Agonist Therapy
An individual with an incretin defect experienced improved glucose control after initiating GLP-1 receptor agonist therapy.
OutcomeSignificant reduction in hemoglobin A1C levels and improved overall health.
Failure to Address Incretin Defects
Neglecting to address incretin defects or imbalances may lead to persistent glucose dysregulation and poor health outcomes.
Research on incretins and their role in glucose regulation has led to the development of this framework, which aims to provide a more comprehensive understanding of incretin-related glucose dysregulation.
Source · PODCAST
Transform Your Metabolic Health & Longevity by Knowing Your Unique Biology | Dr. Michael Snyder